RevStream
About
What does RevStream do?
RevStream is a technology-first company focused on the healthcare industry, delivering intelligent automation, scalable cloud infrastructure, and AI-driven solutions. They aim to enhance efficiency, accuracy, and workflows for physicians, health systems, and billing firms worldwide, allowing them to focus on patient care. Their solutions include AI live scribing for clinical conversations and end-to-end intelligent automation for complex processes.
Is RevStream trustworthy and reputable?
StartupHub's Data Trust & Reputation score for RevStream is 65 out of 100, based on site security posture and privacy practices.
When was RevStream founded?
RevStream was founded in 2026.
What industry does RevStream operate in?
RevStream operates in HealthTech, AI-Driven Workflow Automation, Medical Scribing, Clinical Documentation, Speech Recognition, Natural Language Processing.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI-powered platform for personalized weight management and health coaching.
Clinical Trial Discovery by ENSCORE.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
SYLARIS™ offers premium wearable wellness patches and clinical-grade skincare designed for effortless, intentional, and beautifully designed self-care rituals.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Purpose-built WordPress plugins for healthcare and the agencies that serve them.
An entrant is a company tagged HealthTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 6 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.